Skip to main content
logo
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.270
+0.040 (3.25%)
At close: Aug 21, 2026, 4:00 PM EDT
1.290
+0.020 (1.57%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Actuate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-20.45-22.23-27.29-24.74-20.16
Stock-Based Compensation
6.046.0520.420.65
Other Operating Activities
0.160.022.350.12-0.02
Change in Accounts Payable
-2.12-0.51-1.51.290.59
Change in Other Net Operating Assets
-3.46-2.532.61.281.15
Operating Cash Flow
-19.84-19.21-21.84-21.63-17.79
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
--5.7--
Total Debt Issued
--5.7--
Short-Term Debt Repaid
---0.2--
Total Debt Repaid
---0.2--
Net Debt Issued (Repaid)
--5.5--
Issuance of Common Stock
18.4624.0323.96--
Other Financing Activities
-0.16-0.3-1.93--
Financing Cash Flow
17.7723.7227.534.1319.26

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-2.074.525.68-17.491.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Levered Free Cash Flow
-12.47-11.04-12.39-12.64-
Unlevered Free Cash Flow
-12.46-11.03-12.38-12.61-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
0.070.070.07--
Cash Income Tax Paid
000--
Change in Working Capital
-5.58-3.051.12.571.73
SEC Filings: 10-K · 10-Q